Insights on Non-Alcoholic Steatohepatitis Management
Author Information
Author(s): Navik Umashanker, Khurana Amit, Singh Bhatti Jasvinder
Primary Institution: Central University of Punjab, Bathinda, India
Conclusion
The studies highlight the importance of gender-specific treatments and novel predictive tools for early detection of non-alcoholic steatohepatitis (NASH).
Supporting Evidence
- Genistein has been shown to reduce obesity and insulin resistance in female mice.
- HIF-2α exacerbates fibrosis in NAFLD through chronic hypoxia.
- ALT is an effective marker for screening NAFLD, especially in males.
- Higher glucose-to-albumin ratio is positively correlated with increased NAFLD risk.
Takeaway
This article talks about how different treatments for liver disease can work better for men and women, and how new tests can help find liver problems early.
Limitations
Further studies are required to validate new predictive tools and consider gender-specific approaches in screening.
Participant Demographics
The studies involve gonadectomized mice as a model for hormonal changes related to metabolic dysfunction, and human populations exposed to chronic hypoxia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website